Effectiveness of 67Ga scintigraphy in the diagnosis of lymphoma relapse;Efectividad de la gammagrafía con 67Ga en el diagnóstico de recidiva de linfomas

Revista Espanola de Medicina Nuclear

Volumn 21, Issue 2, 2002, Pages 88-92

  Alvarez Ruiz S ^a   Rodeno Ortiz De Zarate E ^a   Alonso Colmenares, I ^a   Cortes Hernandez J ^a   Alcorta, P ^a  

^a HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Diagnostic; Lymphoma; Recurrence

Indexed keywords

GALLIUM CITRATE GA 67; CITRIC ACID; DIAGNOSTIC AGENT; GALLIUM; GALLIUM CITRATE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER RELAPSE; CANCER SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; RECURRENT CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY SCINTISCANNING; ADOLESCENT; CANCER STAGING; DISEASE COURSE; EVALUATION; FOLLOW UP; LABORATORY DIAGNOSIS; LYMPHOMA; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; CITRATES; DISEASE PROGRESSION; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GALLIUM; GALLIUM RADIOISOTOPES; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036546521     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(02)72041-7     Document Type: Article

References (15)

1. Costello P, Mauch P. Radiographic features of recurrent intrathoracic Hodgkin's disease following radiation therapy. AJR Am J Roentgenol 1979;133:201-6.
2. Torrey MJ, Poen JC, Hoppe RT. Detection of relapse in early stage Hodgkin's disease: role of routine follow-up studies. J Clin Oncol 1997;15:1123-30.
3. North LB, Fuller LM, Sullivan-Halley JA, Hagemeister FB. Regression of mediastinal Hodgkin's disease after therapy: evaluation of time interval. Radiology 1987;164:599-602.
4. Weeks JC, Yeap BY, Cannellos GP, et al. Value of follow-up procedures in patients with large cell lymphoma who achieve a complete remission. J Clin Oncol 1991;9:1196-203.
5. Klimo P, Connors JM. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV hybrid program. Semin Hematol 1988;25:34-40.
6. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standarize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244-53.
7. Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastina radiotheraphy monitored by 67gallium scan in 50 patients. Blood 1999;94:3289-93.
8. Front D, Bar Shalom R, Epelbaum R, et al. Early detection of lymphoma recurrence with 67gallium scintigraphy. J Nucl Med 1993;34:2101-4.
9. 201Tl to monitor mediastinal involvement after treatment. Radiology 1998;209:471-5.
10. 67gallium scintigraphy in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1996;14:1936-42.
11. 67Ga scintigraphy for the evaluation of recurrences and masses in patients with lymphoma. Nucl Med Commun 1997;18:405-11.
12. Hagemeister F, Fesus SM, Lamki LM, et al. Role of the gallium scan in Hodgkin's disease. Cancer 1990;65:1090-6.
13. Heron CW, Husband JE, Williams MP, Cherryman GR. The value of thoracic computed tomography in the detection of recurrent Hodgkin's disease. Br J Radiol 1998;61:567-72.
14. 99mTc-labeled LL2-Fab (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma. Cancer Research 1995;55(Supl):5771-3.
15. Waxman AD, Eller D, Ashook G, et al. Comparison of Gallium-